Poor
Not Aligned
Patient Risk:
High
Summary
Overall alignment is poor due to multiple partially supported/unsupported safety claims and at least one direct contradiction regarding pregnancy outcomes (miscarriage/premature birth).
Category Scores
Accurate Statements
Aspirin can trigger asthma attacks in some individuals, particularly those with pre-existing respiratory conditions.
Supported by contraindication/allergy section: aspirin is contraindicated in patients with asthma/rhinitis/nasal polyps and may cause bronchospasm.
Aspirin should not be given to children under 18 due to the risk of Reye's syndrome, a rare but potentially life-threatening condition.
Supported by Reye syndrome contraindication: do not use aspirin in children or teenagers with viral infections due to risk of Reye syndrome (nuance: label wording is tied to viral infections).
Unsupported Statements
Long-term aspirin use has been linked to kidney damage and increased risk of kidney disease.
Provided label sections only state to avoid aspirin in severe renal failure; they do not support a claim about long-term kidney damage or increased kidney disease risk.
Aspirin can exacerbate bleeding disorders, such as hemophilia.
Provided label discusses general bleeding risk but does not mention hemophilia or exacerbation of specific bleeding disorders.
Dosage adjustments of aspirin can help mitigate side effects.
The provided label excerpts do not include guidance that dosage adjustments mitigate side effects.
Contradictions
High
AI Statement
Aspirin can increase the risk of miscarriage and premature birth.
Label Reference
8.1 Pregnancy: available data have not identified a clear association between aspirin/dipyridamole use and major birth defects or miscarriage; no clear association with miscarriage is stated in provided text.
Important Omissions
No mention that aspirin-containing product warnings include GI bleeding signs (ulceration/bleeding alerts) and counsel patients accordingly.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
A direct contradiction exists for pregnancy outcomes (miscarriage risk), and multiple other claims are unsupported or only partially supported (e.g., kidney damage linkage, hemophilia exacerbation, specific GI symptom inclusion, and generalized mitigation strategies).
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
Pregnancy risk claim contradicts provided pregnancy section; multiple safety claims are unsupported/partially supported by the provided label excerpts.
Suggested Improvement
Remove or revise the miscarriage/premature birth claim to align with the provided pregnancy section stating no clear association with miscarriage; restrict other claims to wording explicitly supported in the provided label excerpts (e.g., do not add diarrhea/kidney damage/hemophilia claims unless supported, and avoid unfounded statements about dose adjustment as mitigation).